Buy & Sell Charles Schwab Corporation Common Stock (SCHW) – Charles Schwab Corporation Common Stock Price Today
Aura AI Summary
Key Stats
- $158.05BMarket Cap
- FinancialsSector
- -12.41%3M Drawdown
- -Enterprise Value
- 1.41%Dividend Yield
- 76% Buy | 24% SellTrading Activity
- 80 daysTypical Hold Time
Charles Schwab Corporation Common Stock (SCHW) is currently valued at a market capitalization of $158.05B. Over the past 52 weeks, Charles Schwab Corporation Common Stock has traded between a low of $87.24 and a high of $107.21, highlighting its annual price range. Over the past three months, Charles Schwab Corporation Common Stock has recorded a drawdown of -12.41%, reflecting recent price volatility. Charles Schwab Corporation Common Stock offers a dividend yield of 1.41%, with the most recent dividend of $0.32 paid on 08 May 26. On average, investors hold Charles Schwab Corporation Common Stock for approximately 80 days, indicating typical investor behavior on the platform.
About Charles Schwab Corporation Common Stock
Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Most Recent News
Hedge funds boost semiconductor bets as SOXX ETF exposure hits record highs in Q1 2026
In the first quarter of 2026, hedge funds dramatically increased their investments in semiconductor stocks, pushing sector exposure to a record 19% of global hedge fund portfolios, more than doubling since the start of the year. Major investors like ...

Onconetix shares jump 23.65% after clinical study boosts confidence in prostate cancer test Proclarix.
Onconetix Inc. stock surged 23.65% in after-hours trading following positive clinical validation of its prostate cancer blood test, Proclarix. Two new peer-reviewed studies from Denmark showed Proclarix can reduce unnecessary biopsies and overdiagnos...

Utilities ETF up 1.65% in quarter, driven by data center growth and renewables partnerships.
The Virtus Reaves Utilities ETF rose 1.65% in the quarter but lagged the S&P 500 Utilities Index, while delivering a 25.49% return over the past year. Key utilities like Entergy and Meta expanded their power generation commitments by 5 gigawatts to s...
